Postpartum changes in methadone maintenance dose
- PMID: 24953167
- PMCID: PMC4111958
- DOI: 10.1016/j.jsat.2014.04.004
Postpartum changes in methadone maintenance dose
Abstract
The optimal approach to postpartum dosing among women treated with methadone maintenance is unclear. We examined doses among 101 methadone-maintained pregnant women 2, 6 and 12 weeks postpartum, and compared the incidence of having doses held for oversedation during pregnancy and postpartum. The average dose at delivery was 83.3mg, and the mean change from delivery to 12 weeks postpartum was -3.7 mg (95% CI -6.3, -1.1). The incidence of oversedation events per 10,000 days was 2.8 among pregnant women and 5.6 for postpartum women (incidence rate ratio [IRR] 2.04, 95% CI 0.66, 6.28). After adjusting for benzodiazepine prescriptions, the IRR of an oversedation event among postpartum women compared to pregnant women was 1.74 (95% CI 0.56, 5.30). In conclusion, postpartum dose changes were small in a methadone clinic using clinical assessments to determine dose. Although the incidence of oversedation events remained low postpartum, the clinically important but not statistically significant increase in events among postpartum women and those prescribed benzodiazepines requires further research. While there are not yet adequate data to support pre-specified postpartum dose reductions, the findings suggest that more frequent clinical assessments continuing as late as 12 weeks postpartum may be warranted.
Keywords: Methadone maintenance treatment; Opioid dependence; Postpartum; Pregnancy.
Copyright © 2014 Elsevier Inc. All rights reserved.
Figures
References
-
- Albright B, de la Torre L, Skipper B, Price S, Abbott P, Rayburn W. Changes in methadone maintenance therapy during and after pregnancy. Journal of Substance Abuse Treatment. 2011;41:347–353. - PubMed
-
- Center for Substance Abuse Treatment. Medication-Assisted Treatment for Opoid Addiction in Opioid Treatment Programs (Treatment Improvement Protocol (TIP) Series 43) Rockville, MD: Substance Abuse and Mental Health Services Administration; 2005. - PubMed
-
- Cleary B, Eogan M, O'Connell M, Fahey T, Gallagher P, Clarke T, White M, McDermott C, O'Sullivan A, Carmody D, Gleeson J, Murphy D. Methadone and Perinatal Outcomes - a Prospective Cohort Study. Addiction. 2012;107:1482–1492. - PubMed
-
- Daley M, Argeriou M, McCarty D. Substance abuse treatment for pregnant women: a window of opportunity? Addictive Behaviors. 1998;23:239–249. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical